SUTENT

Capsule, hard, 50mg
RxActive license

Active substance (INN)

sunitinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength50mg
PackagingUkupno 28 kapsula tvrdih u blisteru (4x7) u kartonskoj kutiji
ManufacturerPfizer Italia S.r.l., Italy
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX01)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateNovember 8, 2022

Analogs in Montenegro

20

Other medicines with the same active substance

Source: CInMED register